Showing results (41-50 of 523) with videos related to
Sort By:
Pageof 53
Clinical Therapeutics|January 30, 2004
Losartan and other angiotensin II antagonists for nephropathy in type 2 diabetes mellitus: a review of the clinical trial evidenceLuis M Ruilope, Julian SeguraJournal of the Renin-Angiotensin-Aldosterone System : JRAAS|November 11, 2003
New-onset diabetes and antihypertensive therapy: comments on ALLHAT trialCristina Sierra, Luis M RuilopeJournal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|June 2, 2009
Kidney protection: a key target in the management of patients with diabetesLuis M Ruilope, Julian SeguraCurrent Opinion in Immunology|March 10, 2018
P2X receptor-ion channels in the inflammatory response in adipose tissue and pancreas-potential triggers in onset of type 2 diabetes?Ivana Novak, Anna SoliniCardiovascular Diabetology|June 5, 2016
The EMPA-REG outcome study: critical appraisal and potential clinical implicationsGianluca Perseghin, Anna SoliniNature Reviews. Endocrinology|February 8, 2012
SGLT2 inhibition in diabetes mellitus: rationale and clinical prospectsEle Ferrannini, Anna SoliniAdvances in Chronic Kidney Disease|December 19, 2021
Glucagon-Like Peptide-1 Receptor Agonists-Use in Clinical PracticeDomenico Tricò, Anna SoliniDiabetes, Obesity & Metabolism|June 28, 2024
Clinical efficacy and cost-effectiveness of metformin in different patient populations: A narrative review of real-world evidenceAnna Solini, Domenico TricòJournal of the American Society of Nephrology : JASN|June 7, 2005
Antihypertensive treatment and multifactorial approach for renal protection in diabetesPaola Fioretto, Anna SoliniCurrent Opinion in Pharmacology|April 8, 2019
Role of the P2X7 receptor in the pathogenesis of type 2 diabetes and its microvascular complicationsAnna Solini, Ivana NovakPageof 53